REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 204 filers reported holding REATA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.50 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $350,000 | +27.7% | 2,476 | -10.0% | 0.01% | +33.3% |
| Q1 2021 | $274,000 | -22.6% | 2,752 | -4.0% | 0.01% | -14.3% |
| Q4 2020 | $354,000 | -79.8% | 2,866 | -84.1% | 0.01% | -85.1% |
| Q3 2020 | $1,754,000 | -24.8% | 18,000 | +20.4% | 0.05% | -29.9% |
| Q2 2020 | $2,333,000 | +12.2% | 14,954 | +3.8% | 0.07% | -17.3% |
| Q1 2020 | $2,080,000 | -1.1% | 14,412 | +40.1% | 0.08% | +138.2% |
| Q4 2019 | $2,103,000 | +772.6% | 10,288 | +242.9% | 0.03% | +580.0% |
| Q3 2019 | $241,000 | – | 3,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |